Have you ever felt that your doctor wasn’t being completely honest with you about all of the tests they were performing and your diagnosis? It turns out that you could very well have been right. The AP recently published an article (Study Finds MDs Not Always Honest with Patients; Lauren Neegaard- February 8, 2012) and revealed some frightening statistics.
The article summarized the findings of a 2009 Massachusets researchers survey of over 1,800 doctors nationwide.
Twenty percent of those surveyed admitted to not fully disclosing a mistake that they had made, and 30% didn’t feel that a doctor should always admit to a mistake. The findings did not specify why doctors felt that way or what mistakes they had not disclosed. Ten percent of doctors even admitted to actually lying to a patient within the last year.
These findings raise major flags about the current healthcare system. If you can’t trust your doctor to be honest with you, who can you trust?
If you believe that you or a loved one is a victim of medical malpractice in New Jersey or New York, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997.
Recognized as one of the leading medical malpractice and personal injury law firms in the area, Gersowitz, Libo & Korek, P.C. has recovered hundreds of millions of dollars for their clients’ medical malpractice and personal injury claims in New York and New Jersey. To find out more about attorneys Edward H. Gersowitz, Jeff S. Korek, Michael A. Fruhling, Brielle C. Goldfaden and Nicolas Bagley, visit http://www.lawyertime.com.
NY Hospitals To Test Medical Malpractice Pilot Program
Five New York Hospitals are becoming part of a malpractice pilot program aimed at reducing medical errors. This three year program will be funded by the federal government for $3 million. While in this program, these hospitals will disclose medical errors early, offer settlements more quickly, and enlist the help of specialized judges to mediate these settlements before they go to trial.
This main goal of this pilot program is to reduce preventable medical mistakes by causing doctors and hospitals to admit their errors and learn from their mistakes. The secondary goal is to reduce costs of medical malpractice insurance.
Patients and their families will be encouraged to take part in this program, but will not be required to. If a patient agrees to participate in the program but a settlement cannot be reached, they still retain the right to seek a jury trial.
The five hospitals participating in this, according to the New York State Department of Health, are: Beth Israel Medical Center, Mount Sinai Medical Center, Maimonides Medical Center, Montefiore Medical Center, and New York Presbyterian Hospital.
While we fully support any program that aims to increase patient safety and limit medical errors, our main concern is that victims of medical malpractice are treated with dignity and not victimized twice- first by the hospitals and then by the legal system.
We will keep track of this pilot program over the next three years and report back on its effectiveness.
Other media outlets who have reported on this pilot program:
Wall Street Journal: Mediating Malpractice
Renal and Urology News: New York Hospitals Test Malpractice Program
Kahn, Gordon, Timko & Rodriques, P.C.: NY Pilot Program Aimed at Reducing Preventable Medical Mistakes
Kaiser Health News: NY Hospitals Agree To Pilot Program To Cut Medical-Malpractice Costs
The Most Injured Victims Are Victimized By Maryland Law
Caps on Wrongful Death and Medical Malpractice Severely Limit Recoveries for Pain and Suffering (Non-Economic Damages)
In 2006, five year old Connor Freed tragically drowned in a country club swimming pool. Connor’s parents, the Freed family, successfully sued the pool company and were awarded by a jury over $4 million in damages for their grief and mental anguish.
Even though the jury found the pool company liable for $4 million, due to Maryland’s cap on all non-economic damages, the award was reduced to just over $1 million. In 2006, the cap on a victim’s wrongful death with two or more survivors was $1.02 million.
The Maryland Cap on Non-Economic Damages was put in place in 1986. In 1994, the cap was raised from $350,000 to $500,000, with an increase of $15,000 each year on October 1. The cap was put in place on the theory that liability insurance would be more affordable and accessible to individuals and organizations that need it.
The Freed family challenged the constitutionality of this cap with Maryland’s Highest Court, the Court of Appeals (DRD Pool Service v. Freed). They argued that this cap violated the right to redress (Article 19), the right to a jury trial (Articles 5 and 23) of the Maryland Declaration of Rights, and the guarantee of equal protection under the 14th Amendment to the U.S. Constitution.
The Appeals Court claimed that stare decisis (to stand by the thing decided) was the basis for their determination as to whether they would overturn this precedent, since they had already upheld the constitutionality of it on two other occasions (Oaks v. Connors and Murphy v. Edmunds). The Court stated that it is only appropriate to overturn a precedent when the decision is clearly wrong and contrary to established principles or when significant changes in other laws or facts invalidate the precedent.
The Court found that this cap did not violate either circumstance, and stare decisis would not be abandoned. The Court further held that this cap did not interfere with the right to a trial by jury, as a jury of one’s peers still evaluates the facts presented and evaluates the negligence of the parties. The Court concluded that the cap did not prevent a plaintiff from full redress; it simply modifies the law of damages to be applied in tort cases.
The Court also ruled that the 14th Amendment to the U.S. Constitution- the guarantee of equal protection- was not violated. The Freeds argued that those who are less seriously injury are entitled to keep everything awarded by a jury for non-economic damages, while those who are more seriously injured and deserving of more are limited by the cap; thus creating a clear classification and violation. While the Court agreed that this cap would technically favor one party over another, it did not create a classification that would justify heightened scrutiny or review.
Insurance companies and big business argue that other States should implement caps. They contend that caps are necessary to curtail jury awards that they believe are too high to appropriately compensate the injured party. This argument, however, is invalid.
In most States, higher courts act as a safeguard to evaluate whether a jury’s award for non-economic damages is excessive or fair and reasonable. If a defendant believes that a damage award is too high, the defendant has a right to appeal the decision to the Appellate Court. In most instances, the Appellate Court will issue a well reasoned decision outlining the factors involved in maintaining, reducing or increasing a jury’s award.
Simply put, a cap on non-economic damages hinders one’s rights and circumvents the role of a jury. Fortunately, the Citizens of New York and New Jersey have curtailed any effort to put in place caps on recoverable damages for victims of medical malpractice, personal injury or wrongful death.
You can view a full transcript of the DRD Pool Service v. Freed by clicking on the name.
For a summary of New York malpractice law, check out the link.
"Level of Awareness" of Comatose Patients Determines Damages for Pain & Suffering
On October 4, 1996, Edith Schaffer suffered a seizure after admitting herself to a psychiatric hospital (Stony Lodge Hospital) in Ossining, NY. After the seizure occurred, she was transferred to a local hospital, and her seizures continued for the next two days. Ms. Schaffer lapsed into a coma, which she remained in for over four years until her death on June 6, 2001. It was determined that her coma was caused by the failure of the physician at the local hospital to diagnose hyponatremia (critically low sodium levels).
A Westchester county jury found the doctor who treated her at the community hospital, Binda Batheja, fully liable for not appreciating the significance of Mrs. Schaffer’s condition. The condition is easily treatable and reversible. The jury awarded $5 million for Mrs. Schaffer’s pain and suffering and $3 million for her husband’s loss of services.
The defense appealed the decision (Schaffer v. Batheja), claiming that it was excessive. The Defendant requested that the appellate court either completely set aside the verdict or at least drastically reduced the sums awarded.
Damages for Pain & Suffering
In order to be awarded damages for pain and suffering, the injured person must demonstrate “some level of awareness of his / her condition and pain level. Claims based upon conjecture, surmise or speculation regarding the person’s ability to appreciate pain will be dismissed by the Court. This standard was set forth by the New York Court of Appeals in McDougald v. Garber (1989).
In Schaffer, the plaintiff attorneys argued that Mrs. Schaffer definitely had some level of awareness of her pain and suffering. The attorney presented medical testimony that Mrs. Schaffers movements in response to outside stimuli demonstrated some level of awareness of her condition.
The defense for Batheja (who died before Mrs. Schaffer and was never disposed in the lawsuit), argued that there was not enough proof that Mrs. Schaffer had any level of awareness. They contended that Mrs. Schaffer’s movements were purely reflexive. In addition, the medical records showed that Mrs. Schaffer was comatose at all times with no ability to communicate or consciously express her pain.
The jury did not believe the defendant’s arguments and awarded Mrs. Schaffer’s estate $5 million dollars for the almost five years of her pain and suffering. The Appellate Division reduced the jury’s award to $2.5 million. Despite the reduction in the jury’s award, the Appellate Division determined that the medical proof submitted in support of Mrs. Schaffer’s claim was sufficient to prove that she was, at times, able to appreciate her pain.
This decision remains a small victory for the many individuals who remain or have been in an vegetative state or coma to seek recovery for their years of suffering. It is important for any person or family member who is interested in pursuing such a claim on behalf of the injured party to document instances of awareness, such as eye movements, crying or tearing, grabbing of hands or other purposeful movements.
Read more about the Schaffer v. Batheja case and outcome on the New York Case Injury Blog website.
How Safe are Off-Label Prescriptions?
Drug Used to Treat Post-Traumatic Stress Disorder for Soldiers May Be Deadly
Seroquel, an anti-psychotic drug approved by the Food and Drug Administration (FDA) to treat schizophrenia, bi-polar disorders, and depression, has been on the market for years. Over the past few years, AstraZeneca, the manufacturer for Seroquel, began marketing this drug to help treat post-traumatic stress disorder (PTSD), insomnia and other conditions not approved by the FDA.
Studies were recently conducted on the side effects of Seoquel. Vanderbuilt University published a study noting that sudden heart failure may be a new side effect. The FDA and AstraZeneca are both reviewing this study to determine its accuracy.
In October of 2009, AstraZeneca paid out $520 million dollars as part of settlement agreements for two federal investigations over clinical trials and off-label promotion, and two whistle-blower lawsuits over aggressive sales and marketing. Details of the federal investigations and whistle-blower lawsuits were not made public. This $520 million barely made a dent in this multi-billion dollar drug, with sales since 2004 totaling over $17 billion.
One of Seroquel’s most recent uses has been for treatment of post-traumatic stress disorder in American soldiers, claiming the drug helps alleviate symptoms of insomnia and restlessness. Thousands of soldiers have been treated for this disorder with Seroquel over the last nine years.
The Associated Press reported on one soldier, Andrew White, who was prescribed the drug after a nine month tour in Iraq after showing signs for PTSD. As his nightmares continued, his dosages of Seroquel were increased over time, and he was taking more than double the maximum dose prescribed to those using it for schizophrenia.
Not long after started this increased dosage, White died in his sleep. There have been atleast a half-dozen deaths among soldiers taking this drug to treat PTSD, but that number is likely grossly understated.
This story raises a much bigger issue. Psychiatrists are allowed to prescribe this drug off-label, which means they can prescribe this drug for unapproved indication. Off-label prescriptions tend to be common place in today’s pharmaceutical-driven society, especially since the FDA procedures to approve a drug are costly and time-consuming.
There is generally substantial literature to support off-label usage, which is what doctors will use to determine whether to prescribe these drugs. Doctors have the ability to issue any drug for an unapproved reason, as long as they use their professional judgment to deem it safe and effective for the condition they are prescribing it for.
Isn’t it time that the FDA crack down on the off-label use of drugs as the risks seem to outweigh any potential benefit?
For more information on the Seroquel case, read the Associated Press article: http://www.google.com/hostednews/ap/article/ALeqM5iPPHBQ6w28w4kTXzANGm6kCzPN1gD9HTRUQ80
For more information on Off-Label Prescriptions, read this article by the American College of Physicians: http://www.annals.org/content/145/4/305.full?etoc
If you or anyone you know has been adversely affected by using Seroquel, contact Gersowitz Libo & Korek, P.C. at 800-529-9997
TORT REFORM
Threatening the Rights of Medical Malpractice Victims
In recent years, proponents of tort reform have lobbied to enact laws which limit the rights of individuals to seek redress in our courts. Such legislation has often been geared towards the area of medical malpractice litigation. Tort reform advocates claim that frivolous lawsuits and out of control jury verdicts are overwhelming our courts. Proponents further argue that medical malpractice suits are responsible for driving up doctor’s insurance rates and driving doctors out of business. In response to these claims, states across the country have enacted laws which limit the rights of individuals in their personal injury lawsuits. Tort reform measures include placing caps on the amount of non-economic damages an individual can recover and enacting procedural barriers for plaintiffs attempting to commence a lawsuit.
While tort reform advocates argue that these limitations something enough times doesn’t make it true. In fact, in a 2006 study published in the New England Journal of Medicine, researchers from the Harvard School of Public Health concluded that [P]ortraits of a malpractice system that is stricken with frivolous litigation are overblown. Additionally, a study by the Congressional Budget less than 2% of healthcare spending. At Gersowitz Libo & Korek, P.C., we believe that limiting individuals rights through tort reform is not the answer. Personal Injury lawsuits compensate individuals for real losses, including medical expenses and lost wages as well as for pain and suffering. In a country with rapidly rising health care costs, being compensated through a personal injury lawsuit should not be equated with winning the lottery. Legislation should not be health care providers at the expense of patients and consumers. Anyone can be a victim of medical malpractice or someone else’s negligence. If you think you or a loved one has been the victim of medical malpractice please contact Gersowitz Libo & Korek, P.C. at (212)385-4410 or visit us online at www.lawyertime.com.
Spotlight on Potentially Dangerous Prescription Drugs – Avandia
Prescription drugs with unhealthy, dangerous, and potentially deadly side-effects are a persistent cause of debilitating injury to Americans. The Food and Drug Administration (FDA) is the lead governmental agency tasked with overseeing issues of drug safety, and in instances of immediate danger it is empowered to issue recall orders for products deemed harmful. In February 2010, following years of scientific studies, the FDA was formally petitioned for a ban and recall of the prescription drug Avandia.
Avandia by GlaxoSmithKline
Avandia is a commonly prescribed drug that is intended to assist those with Type-2 Diabetes gain control of their blood glucose levels. It was first released by GlaxoSmithKline in 1999, and is known generically as thiazoliodinedione. Initial data regarding side-effects from the use of Avandia noted the potential for the following fatal side-effects:
- Heart attack [interruption of blood supply to the heart]
- Congestive heart failure [insufficient or failed cardiac output]
- Stroke [interruption of blood supply to the brain]
- Pulmonary embolism [blood clotting within the lungs]
Additional side-effects, of an immediately non-fatal though damaging nature, are:
- Bone fractures, particularly in the extremities
- Pulmonary hypertension [excessive blood pressure within the lungs]
Several patient factors were found to contribute to elevated risk, including history of heart attack, heart disease, liver disorders, stroke, congestive heart failure, diabetes-related vision problems, and/or high blood pressure/hypertension. Increased incidence of hypoglycemia (dangerously low blood sugar) was noted in Avandia patients that were also taking birth control pills, diuretics, asthma medications, steroids, anti-convulsant drugs, and/or thyroid medications.
Historic FDA Warnings Regarding Avandia
Reports of these side-effects have provoked numerous lawsuits, as well as action by the FDA to warn consumers of the potential for harm resulting from the use of Avandia. In 2007, the FDA issued a national alert to health professionals and the public at large warning of these side-effects. The FDA also required GlaxoSmithKline to include so-called ‘black box’ warnings on Avandia labels. Black box warnings are the most serious advisories required by the FDA, and are reserved for warnings about the potential for immediately fatal drug side-effects.
Clinical Evidence of Fatal Side-Effects Resulting from the Use of Avandia
In September 2007, the Cleveland Clinic released the long-awaited results of their study of the side-effects of Avandia, which noted the following conclusions regarding Avandia patients:
- 43% increased likelihood of heart attack
- 50% increased likelihood of congestive heart failure
- 64% increased likelihood of sudden cardiac death
Compensation for Patients Who Have Suffered from Avandia Side-Effects and Complications
Avandia is currently under review by the FDA for a potential recall announcement. Despite the fact that a recall has not yet been announced, the evidence for both fatal and non-fatal side-effects resulting from the use of Avandia is abundant.
If you or your loved ones have been injured as a result of taking Avandia, you may be entitled to compensation. Contact Gersowitz Libo & Korek, P.C. for a free consultation in order to explore your full legal rights. We are experienced litigators in the field of drug injury & liability, and our team of skilled attorneys has the experience, knowledge, and determination to ensure that you receive the full recompense that you are legally entitled to.



